IBDEI0L9 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10406,1,2,0)
 ;;=2^MUMPS
 ;;^UTILITY(U,$J,358.3,10406,1,3,0)
 ;;=3^86486
 ;;^UTILITY(U,$J,358.3,10407,0)
 ;;=86580^^63^681^5^^^^1
 ;;^UTILITY(U,$J,358.3,10407,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10407,1,2,0)
 ;;=2^TB
 ;;^UTILITY(U,$J,358.3,10407,1,3,0)
 ;;=3^86580
 ;;^UTILITY(U,$J,358.3,10408,0)
 ;;=95024^^63^681^3^^^^1
 ;;^UTILITY(U,$J,358.3,10408,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10408,1,2,0)
 ;;=2^INTRADERMALS (EACH)
 ;;^UTILITY(U,$J,358.3,10408,1,3,0)
 ;;=3^95024
 ;;^UTILITY(U,$J,358.3,10409,0)
 ;;=86510^^63^681^2^^^^1
 ;;^UTILITY(U,$J,358.3,10409,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10409,1,2,0)
 ;;=2^HISTOPLASMOSIS
 ;;^UTILITY(U,$J,358.3,10409,1,3,0)
 ;;=3^86510
 ;;^UTILITY(U,$J,358.3,10410,0)
 ;;=99395^^63^682^1^^^^1
 ;;^UTILITY(U,$J,358.3,10410,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10410,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT 18-39
 ;;^UTILITY(U,$J,358.3,10410,1,3,0)
 ;;=3^99395
 ;;^UTILITY(U,$J,358.3,10411,0)
 ;;=99396^^63^682^2^^^^1
 ;;^UTILITY(U,$J,358.3,10411,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10411,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT 40-64
 ;;^UTILITY(U,$J,358.3,10411,1,3,0)
 ;;=3^99396
 ;;^UTILITY(U,$J,358.3,10412,0)
 ;;=99397^^63^682^3^^^^1
 ;;^UTILITY(U,$J,358.3,10412,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10412,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT > 64
 ;;^UTILITY(U,$J,358.3,10412,1,3,0)
 ;;=3^99397
 ;;^UTILITY(U,$J,358.3,10413,0)
 ;;=99385^^63^683^1^^^^1
 ;;^UTILITY(U,$J,358.3,10413,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10413,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT 18-39
 ;;^UTILITY(U,$J,358.3,10413,1,3,0)
 ;;=3^99385
 ;;^UTILITY(U,$J,358.3,10414,0)
 ;;=99386^^63^683^2^^^^1
 ;;^UTILITY(U,$J,358.3,10414,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10414,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT 40-64
 ;;^UTILITY(U,$J,358.3,10414,1,3,0)
 ;;=3^99386
 ;;^UTILITY(U,$J,358.3,10415,0)
 ;;=99387^^63^683^3^^^^1
 ;;^UTILITY(U,$J,358.3,10415,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10415,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT > 64
 ;;^UTILITY(U,$J,358.3,10415,1,3,0)
 ;;=3^99387
 ;;^UTILITY(U,$J,358.3,10416,0)
 ;;=414.01^^64^684^12
 ;;^UTILITY(U,$J,358.3,10416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10416,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,10416,1,5,0)
 ;;=5^Atherosclerosis, native coronary
 ;;^UTILITY(U,$J,358.3,10416,2)
 ;;=CAD, Native Vessel^303281
 ;;^UTILITY(U,$J,358.3,10417,0)
 ;;=413.9^^64^684^2
 ;;^UTILITY(U,$J,358.3,10417,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10417,1,4,0)
 ;;=4^413.9
 ;;^UTILITY(U,$J,358.3,10417,1,5,0)
 ;;=5^Angina Pectoris
 ;;^UTILITY(U,$J,358.3,10417,2)
 ;;=Angina Pectoris^87258
 ;;^UTILITY(U,$J,358.3,10418,0)
 ;;=413.0^^64^684^3
 ;;^UTILITY(U,$J,358.3,10418,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10418,1,4,0)
 ;;=4^413.0
 ;;^UTILITY(U,$J,358.3,10418,1,5,0)
 ;;=5^Angina at Rest
 ;;^UTILITY(U,$J,358.3,10418,2)
 ;;=Angina at Rest^265313
 ;;^UTILITY(U,$J,358.3,10419,0)
 ;;=411.1^^64^684^5
 ;;^UTILITY(U,$J,358.3,10419,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10419,1,4,0)
 ;;=4^411.1
 ;;^UTILITY(U,$J,358.3,10419,1,5,0)
 ;;=5^Angina, Unstable
 ;;^UTILITY(U,$J,358.3,10419,2)
 ;;=Angina, Unstable^7455
 ;;^UTILITY(U,$J,358.3,10420,0)
 ;;=413.1^^64^684^4
 ;;^UTILITY(U,$J,358.3,10420,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10420,1,4,0)
 ;;=4^413.1
 ;;^UTILITY(U,$J,358.3,10420,1,5,0)
 ;;=5^Angina, Prinzmetal
 ;;^UTILITY(U,$J,358.3,10420,2)
 ;;=^7448
 ;;^UTILITY(U,$J,358.3,10421,0)
 ;;=V58.61^^64^684^6
 ;;^UTILITY(U,$J,358.3,10421,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10421,1,4,0)
 ;;=4^V58.61
